早期产前皮质类固醇暴露后足月或晚期早产儿比例及结局:160万婴儿的系统综述与Meta分析
该系统综述与Meta分析纳入7项随机对照试验和10项基于人群的队列研究(共160万婴儿),评估早期(<34周)产前皮质类固醇暴露后足月(≥37周)或晚期早产(34-36周)出生的比例及短期和长期结局。结果显示,约40%早期暴露婴儿足月出生(低或极低确定性)。在足月儿中,与未暴露相比,早期暴露与NICU入住风险增加(调整OR 1.49,95%CI 1.19-1.86;未调整RR 1.69,95%CI 1.51-1.89)、插管风险增加(未调整RR 2.59,95%CI 1.39-4.81)、头围减小(调整均差-0.21,95%CI -0.29至-0.13)及远期神经发育或行为障碍风险增加(调整HR 1.47,95%CI 1.36-1.60)相关(低或极低确定性)。作者结论强调考虑产前皮质类固醇时需谨慎。
要点
- 约40%早期(<34周)产前皮质类固醇暴露婴儿足月(≥37周)出生(低或极低确定性)。
- 足月儿中,早期暴露 vs 未暴露:NICU入住未调整RR 1.69(95%CI 1.51-1.89;3项研究,1 176 022婴儿;I2=58%,τ2=0.01;低确定性);调整OR 1.49(95%CI 1.19-1.86;1项研究,5330婴儿;极低确定性)。
- 足月儿中,早期暴露 vs 未暴露:插管未调整RR 2.59(95%CI 1.39-4.81;绝对效应每1000例增加7例,95%CI 增加2至16例;1项研究,8076婴儿;极低确定性)。
- 足月儿中,早期暴露 vs 未暴露:头围减小调整均差-0.21(95%CI -0.29至-0.13;1项研究,183 325婴儿;低确定性)。
- 基于人群研究中,足月儿早期暴露 vs 未暴露:任何远期神经发育或行为障碍调整HR 1.47(95%CI 1.36-1.60;1项研究,641 487儿童;低确定性)。
适用人群与场景
- 随机对照试验和基于人群的队列研究,纳入早期(<34周)产前皮质类固醇暴露后足月(≥37周)、晚期早产(34-36周)或足月/晚期早产合并出生的婴儿数据。
- 检索8个数据库(2000年1月1日至2023年2月1日)及筛选文章参考文献,反映近期围产期护理。
研究设计与关键结果
- 研究类型:系统综述与Meta分析;纳入7项随机对照试验和10项基于人群的队列研究,共160万婴儿。
- 主要结局:随机对照试验和基于人群数据中,约40%早期产前皮质类固醇暴露婴儿足月出生(低或极低确定性)。
- 足月儿中,早期暴露 vs 未暴露:NICU入住调整OR 1.49(95%CI 1.19-1.86;1项研究,5330婴儿;极低确定性);未调整RR 1.69(95%CI 1.51-1.89;3项研究,1 176 022婴儿;I2=58%,τ2=0.01;低确定性)。
- 足月儿中,早期暴露 vs 未暴露:插管未调整RR 2.59(95%CI 1.39-4.81;绝对效应每1000例增加7例,95%CI 增加2至16例;1项研究,8076婴儿;极低确定性)。
- 足月儿中,早期暴露 vs 未暴露:头围减小调整均差-0.21(95%CI -0.29至-0.13;1项研究,183 325婴儿;低确定性)。
- 基于人群研究中,足月儿早期暴露 vs 未暴露:任何远期神经发育或行为障碍调整HR 1.47(95%CI 1.36-1.60;1项研究,641 487儿童;低确定性)。
证据类型、等级与局限
- 证据类型:系统综述与Meta分析,纳入随机对照试验和基于人群的队列研究;采用Cochrane偏倚风险工具和Newcastle-Ottawa量表评估偏倚风险;随机效应Meta分析。
- 证据确定性:主要结局低或极低确定性;NICU入住调整OR极低确定性,未调整RR低确定性;插管极低确定性;头围减小低确定性;远期神经发育或行为障碍低确定性。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论:约40%早期产前皮质类固醇暴露婴儿足月出生,伴随短期和长期不良结局(低或极低确定性),强调考虑产前皮质类固醇时需谨慎。
指南或共识出处
- 系统综述注册号:PROSPERO CRD42022360079。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To systematically review the proportions of infants with early exposure to antenatal corticosteroids but born at term or late preterm, and short term and long term outcomes.
DESIGN: Systematic review and meta-analyses.
DATA SOURCES: Eight databases searched from 1 January 2000 to 1 February 2023, reflecting recent perinatal care, and references of screened articles.
ELIGIBILITY CRITERIA FOR SELECTING STUDIES: Randomised controlled trials and population based cohort studies with data on infants with early exposure to antenatal corticosteroids (<34 weeks) but born at term (≥37 weeks), late preterm (34-36 weeks), or term/late preterm combined.
DATA EXTRACTION AND SYNTHESIS: Two reviewers independently screened titles, abstracts, and full text articles and assessed risk of bias (Cochrane risk of bias tool for randomised controlled trials and Newcastle-Ottawa scale for population based studies). Reviewers extracted data on populations, exposure to antenatal corticosteroids, and outcomes. The authors analysed randomised and cohort data separately, using random effects meta-analyses.
MAIN OUTCOME MEASURES: The primary outcome was the proportion of infants with early exposure to antenatal corticosteroids but born at term. Secondary outcomes included the proportions of infants born late preterm or term/late preterm combined after early exposure to antenatal corticosteroids and short term and long term outcomes versus non-exposure for the three gestational time points (term, late preterm, term/late preterm combined).
RESULTS: Of 14 799 records, the reviewers screened 8815 non-duplicate titles and abstracts and assessed 713 full text articles. Seven randomised controlled trials and 10 population based cohort studies (1.6 million infants total) were included. In randomised controlled trials and population based data, ∼40% of infants with early exposure to antenatal corticosteroids were born at term (low or very low certainty). Among children born at term, early exposure to antenatal corticosteroids versus no exposure was associated with increased risks of admission to neonatal intensive care (adjusted odds ratio 1.49, 95% confidence interval 1.19 to 1.86, one study, 5330 infants, very low certainty; unadjusted relative risk 1.69, 95% confidence interval 1.51 to 1.89, three studies, 1 176 022 infants, I2=58%, τ2=0.01, low certainty), intubation (unadjusted relative risk 2.59, 1.39 to 4.81, absolute effect 7 more per 1000, 95% confidence interval from 2 more to 16 more, one study, 8076 infants, very low certainty, one study, 8076 infants, very low certainty), reduced head circumference (adjusted mean difference -0.21, 95% confidence interval -0.29 to -0.13, one study, 183 325 infants, low certainty), and any long term neurodevelopmental or behavioural disorder in population based studies (eg, any neurodevelopmental or behavioural disorder in children born at term, adjusted hazard ratio 1.47, 95% confidence interval 1.36 to 1.60, one study, 641 487 children, low certainty).
CONCLUSIONS: About 40% of infants exposed to early antenatal corticosteroids were born at term, with associated adverse short term and long term outcomes (low or very low certainty), highlighting the need for caution when considering antenatal corticosteroids.
SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42022360079.
参考来源
- Ninan K, Gojic A, Wang Y, et al. The proportions of term or late preterm births after exposure to early antenatal corticosteroids, and outcomes: systematic review and meta-analysis of 1.6 million infants. BMJ. 2023. PMID: 37532269. doi:10.1136/bmj-2023-076035
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。